NCT04423315View on ClinicalTrials.gov

Thrombosis Risk Assessment and Clinical Presentation of Covid-19 Pneumonia

CompletedOBSERVATIONAL
Enrollment

70

Participants

Timeline

Start Date

June 8, 2020

Primary Completion Date

July 15, 2020

Study Completion Date

July 20, 2020

Conditions
Corona Virus InfectionThromboembolic Disease
Trial Locations (1)

34230

Vital Hospital, Bahçelievler

All Listed Sponsors
lead

Istanbul Nisantasi University

OTHER

NCT04423315 - Thrombosis Risk Assessment and Clinical Presentation of Covid-19 Pneumonia | Biotech Hunter | Biotech Hunter